Annual ROE
-75.79%
-23.18%-44.06%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual return on equity is currently -75.79%, with the most recent change of -23.18% (-44.06%) on 31 December 2022. During the last 3 years, it has risen by +9.57% (+11.21%).ZYNE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-90.03%
-14.91%-19.85%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly return on equity is currently -90.03%, with the most recent change of -14.91% (-19.85%) on 30 June 2023.ZYNE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +11.2% | -90.3% |
| 5 y5 years | -12.6% | -122.1% |
ZYNE ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -207.6% | -107.0% |
Zynerba Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -90.03%(+19.8%) |
| Mar 2023 | - | -75.12%(+18.7%) |
| Dec 2022 | -75.79%(+44.1%) | -63.30%(+8.7%) |
| Sept 2022 | - | -58.25%(+5.0%) |
| June 2022 | - | -55.50%(+10.9%) |
| Mar 2022 | - | -50.04%(+11.7%) |
| Dec 2021 | -52.61%(-38.4%) | -44.81%(-5.3%) |
| Sept 2021 | - | -47.31%(+0.3%) |
| June 2021 | - | -47.17%(-25.4%) |
| Mar 2021 | - | -63.26%(-17.6%) |
| Dec 2020 | -85.36%(+95.9%) | -76.80%(+3.6%) |
| Sept 2020 | - | -74.16%(+23.2%) |
| June 2020 | - | -60.20%(+30.1%) |
| Mar 2020 | - | -46.27%(+10.3%) |
| Dec 2019 | -43.58%(-35.3%) | -41.94%(+3.5%) |
| Sept 2019 | - | -40.53%(-22.3%) |
| June 2019 | - | -52.19%(-18.5%) |
| Mar 2019 | - | -64.05%(-12.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -67.33%(-4.8%) | -73.16%(+1.7%) |
| Sept 2018 | - | -71.91%(+1.4%) |
| June 2018 | - | -70.93%(+24.4%) |
| Mar 2018 | - | -57.03%(+8.4%) |
| Dec 2017 | -70.72%(+4.8%) | -52.62%(-6.3%) |
| Sept 2017 | - | -56.17%(-5.2%) |
| June 2017 | - | -59.23%(-7.8%) |
| Mar 2017 | - | -64.25%(-8.2%) |
| Dec 2016 | -67.51%(-14.9%) | -69.97%(+16.1%) |
| Sept 2016 | - | -60.27%(-15.5%) |
| June 2016 | - | -71.29%(+7.9%) |
| Mar 2016 | - | -66.08%(-24.4%) |
| Dec 2015 | -79.30%(-212.6%) | -87.35%(-17.6%) |
| Sept 2015 | - | -106.00%(-161.5%) |
| June 2015 | - | 172.46%(-86.6%) |
| Mar 2015 | - | 1290.67%(+1733.1%) |
| Dec 2014 | 70.41%(+32.3%) | 70.41% |
| Dec 2013 | 53.21% | - |
FAQ
- What is Zynerba Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual return on equity?
The current annual ROE of ZYNE is -75.79%
What is the all time high annual ROE for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual return on equity is 70.41%
What is Zynerba Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ZYNE is -90.03%
What is the all time high quarterly ROE for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly return on equity is 1290.67%